cmkxac.wiki • Professional Insights • Expert Commentary • Resource Center
cmkxac.wiki

Top Alternatives,Biotinylation can modify the in vivo activity of a peptide

Leveraging Biotin for Enhanced Peptide Uptake into Cells by HM Said·1999·Cited by 126—This review describes our knowledge ofbiotin transport inthe small intestine of humans and other mammals and presents recent findingsinthe area.

:by

A
Sharon Phillips

researches '' content performance and visibility with structured data analysis across Snapchat and YouTube

Published on

Executive Summary

Biotin-labeled reagents can covalently bind to target proteins by HM Said·1999·Cited by 126—This review describes our knowledge ofbiotin transport inthe small intestine of humans and other mammals and presents recent findingsinthe area.

The intricate process of delivering therapeutic or research molecules into cells is a cornerstone of modern biology and medicine. Among the various strategies explored, utilizing biotin to facilitate peptide uptake into cells has emerged as a promising avenue. This approach leverages the unique properties of biotin, a vital nutrient often referred to as vitamin H, to create pathways for enhanced cellular entry of various peptides.

Research has demonstrated that biotinylated peptides of significant size, up to 31 amino acids in length, can indeed be effectively taken up by cells, such as E. coli. This uptake is not random; it is specifically mediated by the biotin transporter system within the cell. This discovery, detailed in studies by Walker et al., highlights a mechanism where the presence of biotin acts as a key to unlock cellular entry for otherwise challenging cargo like larger peptides.

The fundamental principle behind this strategy lies in the high affinity and specificity of the avidin–biotin interaction. This strong molecular bond is widely exploited in various biological applications, including immunohistochemistry (IHC), where it aids in detection systems. When a peptide is biotin-labeled, it can then be readily bound by avidin or streptavidin. This conjugation can significantly influence the in vivo activity of a peptide. Furthermore, biotin-labeled reagents can covalently bind to target proteins, enabling their subsequent efficient separation through affinity capture processes.

The cellular uptake of biotin itself is a well-studied phenomenon, with various mechanisms and regulatory pathways identified. Studies by Said et al. have explored the nuances of biotin transport in the small intestine and liver cells, indicating that dedicated transport systems exist to move this essential vitamin into the cell. This inherent cellular machinery for biotin uptake can be strategically harnessed. For instance, the biotin transporter can be used in order to take small molecules across the cell membrane. This opens up possibilities for delivering biotin-conjugated molecules, including peptides, directly into the cellular interior.

The design and generation of efficient biotin acceptor peptides are crucial for optimizing this uptake process. Researchers are developing sophisticated methods to create peptides that are effectively recognized and transported when modified with biotin. This involves understanding how biotinylation affects the overall structure and function of the peptide, as well as how it interacts with cellular transport systems.

Beyond direct transport, biotinylation can influence peptide behavior within the body. For example, biotinylated peptides can bind to serum albumin, a common protein in the bloodstream. This binding can alter the peptide's clearance rate, potentially extending its presence and efficacy within the system.

While the primary focus is on enhancing peptide entry, it's important to acknowledge that biotin itself has physiological roles. Biotin functions as a covalently bound cofactor essential for the activity of several critical enzymes, known as biotin-dependent carboxylases. These enzymes are involved in various metabolic processes. However, it's also noted that at pharmacologic concentrations, biotin might interfere with the cellular uptake of other vitamins, such as pantothenic acid, through competitive binding.

The application of biotin-mediated peptide delivery extends to various fields. In targeted drug delivery, biotin-receptor-mediated intracellular delivery of synthetic molecules is being explored. This involves creating biotin-targeted complexes that can selectively deliver therapeutic payloads, such as proteins, into specific cells. The efficiency of this uptake is a key area of ongoing research.

Moreover, biotinylated cell-penetrating peptides are being developed to study intracellular processes. By attaching biotin to known cell-penetrating peptides (CPPs), researchers can facilitate their entry and then use the biotin-avidin pull-down system to investigate intracellular protein-protein interactions. This is particularly useful for studying interactions that occur within the cell's complex environment.

In essence, the strategy of using biotin to help peptide uptake into cells involves a multi-faceted understanding of biotin's molecular properties, cellular transport mechanisms, and its interactions with other biological molecules. The ability to modify peptides with biotin and leverage the cell's own biotin uptake pathways offers a powerful tool for researchers and clinicians aiming to improve the delivery and efficacy of peptide-based therapeutics and research tools. The ongoing exploration of biotin's role in cellular processes, from nutrient absorption to its function as a cofactor, continues to reveal new opportunities for its application in enhancing molecular delivery.

Related Articles

Frequently Asked Questions

Here are the most common questions about .

Uptake of biotin by human hepatoma cell line, Hep G 2
Aminooxy-biotincan be used to covalently attachbiotinto aldehyde or ketone groups on polysaccharides, glycoproteins o Aminooxy-biotin. From 0. Sizes 5 
by J Zempleni·2001·Cited by 71—Biotin at pharmacologic concentrations might interfere with cellular uptakeof pantothenic acid by reversible competition for binding sites (Wang et al. 1999).
by HM Said·1999·Cited by 126—This review describes our knowledge ofbiotin transport inthe small intestine of humans and other mammals and presents recent findingsinthe area.

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More